Corvus Pharmaceuticals
CRVS
CRVS
50 hedge funds and large institutions have $63.2M invested in Corvus Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
60% less call options, than puts
Call options by funds: $104K | Put options by funds: $261K
Holders
50
Holding in Top 10
1
Calls
$104K
Puts
$261K
Top Buyers
| 1 | +$9.56M | |
| 2 | +$1.2M | |
| 3 | +$291K | |
| 4 |
BlackRock
New York
|
+$142K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$112K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$718K | |
| 3 | -$596K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$294K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$148K |